OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationship between risk and protective factors and clinical features of Parkinson's disease
Daniele Belvisi, Roberta Pellicciari, A Fabbrini, et al.
Parkinsonism & Related Disorders (2022) Vol. 98, pp. 80-85
Open Access | Times Cited: 16

Showing 16 citing articles:

The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Ruhul Amin, Cristina Quispe, Anca Oana Docea, et al.
Neurochemistry International (2022) Vol. 158, pp. 105376-105376
Closed Access | Times Cited: 39

Risk factors associated with age at onset of Parkinson’s disease in the UK Biobank
Yuanfeng Huang, Qian Chen, Zheng Wang, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7

Polygenic Risk Score Combined with Transcranial Sonography Refines Parkinson's Disease Risk Prediction
Mart Kals, Anu Reigo, Maris Teder‐Laving, et al.
Movement Disorders Clinical Practice (2025)
Open Access

A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson's disease with insights into screening models
Ayesha Sayyaed, Nikita Saraswat, Neeraj S. Vyawahare, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2023) Vol. 47, Iss. 1
Open Access | Times Cited: 9

Do oral antidiabetic medications alter the risk of Parkinson’s disease? An updated systematic review and meta-analysis
Yanna Xie, Jialiang Wang, Jie Jiang, et al.
Neurological Sciences (2023) Vol. 44, Iss. 12, pp. 4193-4203
Closed Access | Times Cited: 9

Exploring the Association between Cathepsin B and Parkinson’s Disease
Changhao Lu, Xinyi Cai, Shilin Zhi, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 482-482
Open Access | Times Cited: 3

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease
Beatriz Guedes, Sandra M. Cardoso, A. Raquel Esteves
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1349-1349
Open Access | Times Cited: 8

Bayesian network modeling of risk and prodromal markers of Parkinson’s disease
Meemansa Sood, Ulrike Suenkel, Anna‐Katharina von Thaler, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0280609-e0280609
Open Access | Times Cited: 2

Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations
Tommaso Ercoli, Caterina Francesca Bagella, Claudia Frau, et al.
Neurology International (2023) Vol. 16, Iss. 1, pp. 20-32
Open Access | Times Cited: 2

Parkinson and Sexuality
Alessandra Graziottin, Laura Bertolasi
Trends in andrology and sexual medicine (2024), pp. 437-450
Closed Access

Environmental Pollutants and Alpha-Synuclein Toxicity in Parkinson’s Disease
Sudhamoy Roy, Violina Kakoty, Amirhossein Sahebkar, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155605-155605
Closed Access

Risk reduction of Parkinson's disease by caffeinated beverage consumption
Tomoyuki Kawada
Parkinsonism & Related Disorders (2022) Vol. 103, pp. 152-152
Closed Access | Times Cited: 1

The Coffee Revolution: From Politics to Optimized Health
Steven Barag, Amy Robichaux, Taryn Kawashima, et al.
Journal of the Osteopathic Family Physicians of California (2023), pp. 11-18
Open Access

Combined Associations of Genetic and Environmental Risk Factors in Age of Parkinson’s Disease Onset
Jinchen Li, Yuanfeng Huang, Qian Chen, et al.
Research Square (Research Square) (2023)
Open Access

Reply to “Risk reduction of Parkinson's disease by caffeinated beverage consumption”
Daniele Belvisi, Matteo Costanzo, Roberta Pellicciari, et al.
Parkinsonism & Related Disorders (2022) Vol. 103, pp. 15-16
Closed Access

Page 1

Scroll to top